# Risks & Mitigation Strategies

## Overview

Comprehensive risk assessment and mitigation strategies for a health intelligence platform targeting Swiss biohackers. Risks categorized by type: Technical, Market, Regulatory, Business, and Strategic.

---

## Risk Summary Matrix

| Risk Category | Severity | Probability | Priority | Status |
|---------------|----------|-------------|----------|--------|
| **Technical Risks** |
| OCR accuracy failures | High | Medium | High | ⚠️ Monitor |
| API dependency (Oura, Whoop) | High | Low | Medium | ✅ Addressed |
| AI hallucinations/bad advice | Critical | Low | Critical | ✅ Addressed |
| Data security breach | Critical | Low | Critical | ✅ Addressed |
| Scalability/performance issues | Medium | Medium | Medium | ⚠️ Monitor |
| **Market Risks** |
| Limited market size | Medium | High | High | ⚠️ Monitor |
| Low conversion rate | High | Medium | High | ⚠️ Monitor |
| High churn rate | High | Medium | High | ⚠️ Monitor |
| Competitor with more funding | Medium | Medium | Medium | ⚠️ Monitor |
| **Regulatory Risks** |
| Medical device classification | Critical | Low | High | ✅ Addressed |
| Data privacy (GDPR, Swiss DPA) | High | Low | High | ✅ Addressed |
| Medical advice liability | High | Medium | High | ✅ Addressed |
| **Business Risks** |
| Founder burnout | High | Medium | High | ⚠️ Monitor |
| Cash flow issues | Medium | Low | Medium | ✅ Addressed |
| Key person dependency | High | High | High | ⚠️ Monitor |
| Partnership failures | Medium | Medium | Medium | ⚠️ Monitor |
| **Strategic Risks** |
| Wrong product-market fit | High | Low | High | ⚠️ Validate |
| Timing (too early/late) | Medium | Low | Low | ✅ Addressed |
| Pricing strategy failure | Medium | Medium | Medium | ⚠️ Monitor |

---

## Technical Risks

### Risk 1: OCR Accuracy Failures

**Description:**
Platform relies on OCR to extract biomarker data from lab PDFs and photos. Inaccurate extraction could lead to:
- Wrong biomarker values → incorrect analysis → dangerous recommendations
- User frustration (manual corrections required)
- Loss of trust and churn

**Severity:** High (patient safety + trust)

**Probability:** Medium (30-40% - Swiss labs use diverse formats)

**Impact:**
- 5-10% of uploads fail or require manual correction
- User friction reduces conversion rate by 10-20%
- Worst case: Misdiagnosis leads to harm → legal liability

---

#### Mitigation Strategies

**Prevention:**

1. **Multi-Stage OCR Pipeline**
   - Primary: GPT-4 Vision (high accuracy but expensive)
   - Fallback: Tesseract OCR (open source, good for structured PDFs)
   - Final: Human review queue for confidence < 90%

2. **Confidence Scoring**
   - OCR outputs confidence score for each value
   - Values with <90% confidence → flag for user review
   - Show original image alongside extracted data

3. **User Verification Step**
   - After OCR, show extracted values in editable form
   - User confirms or corrects before analysis proceeds
   - "Please verify these values match your lab report"

4. **Lab Format Training**
   - Build library of 100+ Swiss lab formats (Biostarks, Hirslanden, Medisupport, etc.)
   - Fine-tune OCR on Swiss medical document formats
   - Partner with labs for standardized digital export (roadmap)

**Detection:**

5. **Anomaly Detection**
   - Flag physiologically impossible values (e.g., vitamin D = 800 ng/mL)
   - Cross-reference with normal ranges (catch extraction errors)
   - Alert user: "This value seems unusual - please verify"

6. **User Feedback Loop**
   - "Was this extraction correct?" after analysis
   - Track OCR accuracy by lab provider
   - Continuous improvement of OCR models

**Response:**

7. **Manual Review Queue**
   - Low-confidence extractions go to human review
   - Founder reviews (Year 1) → Part-time contractor (Year 2)
   - Target: <5% manual review rate by Month 6

8. **Error Correction Protocol**
   - If user reports OCR error after analysis:
     - Re-run analysis with corrected values
     - Refund or credit if error was significant
     - Log error for model improvement

**Success Metrics:**
- OCR accuracy: >95% by Month 3, >98% by Month 6
- Manual review rate: <5% by Month 6
- User-reported errors: <2% of uploads

---

### Risk 2: API Dependency (Oura, Whoop, Apple Health)

**Description:**
Platform relies on third-party APIs for wearable data. Risks:
- API changes/deprecation → features break
- Rate limiting → performance issues
- Terms of Service changes → forced to remove integration
- Company acquisition → API shut down

**Severity:** High (core feature dependency)

**Probability:** Low (20% - major disruption unlikely in 3 years)

**Impact:**
- Loss of wearable data for affected users
- Core differentiator becomes unavailable
- 30-50% revenue at risk if major integration fails

---

#### Mitigation Strategies

**Prevention:**

1. **Multi-Wearable Strategy**
   - Integrate 4+ wearables (Oura, Whoop, Apple, Garmin)
   - Users can switch if one API fails
   - Diversification reduces single-point-of-failure risk

2. **Official API Partnerships**
   - Use official APIs only (not scraping or reverse engineering)
   - Review Terms of Service quarterly
   - Follow API best practices (rate limiting, caching)

3. **Local Data Storage**
   - Cache wearable data in our database (per ToS)
   - If API fails, still have historical data
   - Can continue analysis on cached data for 30-60 days

4. **Abstraction Layer**
   - Build internal data model (normalized schema)
   - API-specific code isolated in adapters
   - Easy to swap/add new wearables

**Detection:**

5. **API Health Monitoring**
   - Automated tests every 15 minutes
   - Alert if API returns errors or high latency
   - Dashboard showing API uptime per provider

6. **User Impact Monitoring**
   - Track % of users with failed syncs
   - Alert if >5% of users affected
   - Proactive communication if widespread issue

**Response:**

7. **Degraded Mode**
   - If API temporarily down: Use cached data + notify user
   - "Oura API is experiencing issues - using data from yesterday"
   - Continue providing value with available data

8. **Backup Integrations**
   - For Oura: Apple Health integration can pull similar data
   - For Apple Health: User can manually export data
   - CSV import as last resort

9. **Communication Plan**
   - Notify affected users within 1 hour
   - Status page showing integration health
   - Regular updates until resolved

**Success Metrics:**
- API uptime: >99.5% (excluding third-party downtime)
- Mean time to detection: <15 minutes
- Mean time to user notification: <1 hour
- User churn due to API issues: <1%

---

### Risk 3: AI Hallucinations / Bad Medical Advice

**Description:**
GPT-4 may generate plausible-sounding but medically incorrect advice. Risks:
- Dangerous supplement protocols (overdosing, interactions)
- Misinterpretation of biomarkers → wrong root cause
- False reassurance or unnecessary alarm
- Legal liability if user harmed

**Severity:** Critical (patient safety + legal)

**Probability:** Low (10-15% - with no safeguards, would be high)

**Impact:**
- User harm (overdose, adverse reactions, delayed treatment)
- Lawsuits and legal liability
- Regulatory action (platform shut down)
- Reputational damage (news coverage, loss of trust)

---

#### Mitigation Strategies

**Prevention:**

1. **Strict System Prompts**
   - Provide detailed medical guidelines in prompt
   - Include contraindications and safety limits
   - "Never recommend doses above X without medical supervision"
   - "Always include disclaimer about consulting doctor"

2. **Response Validation Layer**
   - Parse AI output for dangerous patterns:
     - Doses above safe limits (e.g., vitamin D >10,000 IU)
     - Known dangerous combinations (e.g., St. John's Wort + medications)
     - Medical claims ("this will cure...")
   - Reject and regenerate if validation fails

3. **Evidence-Based Framework**
   - All recommendations based on 17 proprietary frameworks
   - Frameworks built from peer-reviewed research
   - AI follows frameworks (not hallucinating new protocols)

4. **Human Review for Edge Cases**
   - Flag unusual biomarker combinations for manual review
   - Founder reviews (Year 1) → Medical advisor (Year 2)
   - AI generates draft, human approves before sending

5. **Disclaimers & Legal Protection**
   - Clear disclaimer on every report: "This is wellness guidance, not medical advice"
   - "Always consult your doctor before starting new supplements"
   - Terms of Service: User acknowledges platform is informational only

**Detection:**

6. **User Feedback Loop**
   - "Was this analysis helpful?" after every report
   - "Report an issue" button (flag dangerous advice)
   - Track feedback sentiment (watch for concerning patterns)

7. **Medical Advisor Review (Sample)**
   - Hire functional medicine doctor as advisor (Year 1, Month 6)
   - Review 10% random sample of analyses quarterly
   - Identify systematic issues with AI recommendations

**Response:**

8. **Rapid Issue Resolution**
   - If dangerous advice detected:
     - Immediately notify affected users
     - Offer to consult with human expert (free)
     - Update system prompts to prevent recurrence
   - All user reports reviewed within 24 hours

9. **Incident Response Plan**
   - Document every reported issue
   - Root cause analysis within 48 hours
   - Update frameworks + prompts to prevent repeat
   - Consider refund/credit if significant error

**Success Metrics:**
- User-reported safety issues: 0 (zero tolerance)
- Advisor approval rate on sample reviews: >98%
- Validation layer catches: Track & reduce over time
- Legal incidents: 0

---

### Risk 4: Data Security Breach

**Description:**
Platform stores sensitive health data (lab results, wearable data, personal info). Risks:
- Hacking/breach → data stolen
- GDPR violations → CHF 20M or 4% revenue fine
- Loss of user trust → churn
- Regulatory action (Swiss FDPIC investigation)

**Severity:** Critical (existential threat)

**Probability:** Low (10% - if proper security measures in place)

**Impact:**
- CHF 1,000-20,000 per affected user (GDPR fines)
- 100% user churn (loss of trust)
- Business shutdown (regulatory action)
- Personal liability for founder

---

#### Mitigation Strategies

**Prevention:**

1. **Encryption**
   - At rest: AES-256 encryption for all user data
   - In transit: TLS 1.3 for all connections
   - Database-level encryption (PostgreSQL + pgcrypto)

2. **Access Controls**
   - Role-based access control (RBAC)
   - Principle of least privilege (employees see minimum necessary)
   - Two-factor authentication for all admin accounts
   - Audit logs for all data access

3. **Infrastructure Security**
   - Host on SOC 2 compliant platforms (Vercel, Railway)
   - Web Application Firewall (WAF) via Cloudflare
   - Regular security patches and updates
   - No sensitive data in logs or error messages

4. **Secure Development Practices**
   - Code review for all changes
   - Automated security scanning (Dependabot, Snyk)
   - OWASP Top 10 vulnerability testing
   - Penetration testing annually (Year 2+)

5. **Data Minimization**
   - Only store necessary data
   - Anonymize data for analytics (no PII)
   - Delete user data within 30 days of account deletion

**Detection:**

6. **Monitoring & Alerts**
   - Real-time monitoring for suspicious activity
   - Alert on: mass data exports, unusual login locations, API abuse
   - Security Information and Event Management (SIEM) tool (Year 2)

7. **Regular Audits**
   - Quarterly security audits (internal)
   - Annual third-party security audit (Year 2+)
   - Penetration testing annually

**Response:**

8. **Incident Response Plan**
   - Documented plan for breach response
   - Responsible person: Founder (Year 1) → CTO (Year 2+)
   - Notify Swiss FDPIC within 72 hours (GDPR requirement)
   - Notify affected users within 72 hours
   - Offer credit monitoring services (if financial data exposed)

9. **Breach Insurance**
   - Cyber liability insurance (Year 1: CHF 100K coverage, Year 2: CHF 1M)
   - Covers legal costs, notification costs, fines (if not intentional)

**Success Metrics:**
- Security incidents: 0
- Penetration test findings: All critical/high resolved within 30 days
- GDPR compliance audit: Pass with no major findings
- Encryption coverage: 100% of sensitive data

---

### Risk 5: Scalability / Performance Issues

**Description:**
As user base grows, technical infrastructure may struggle:
- Database slowdowns (complex queries on large datasets)
- API rate limiting (Oura/Whoop have limits)
- AI analysis cost explosion (GPT-4 expensive at scale)
- Page load times increase → poor UX

**Severity:** Medium (doesn't kill business but hurts growth)

**Probability:** Medium (40-50% - will happen without planning)

**Impact:**
- Poor user experience → 10-20% churn increase
- Higher infrastructure costs → margin compression
- Inability to onboard new users (growth stall)

---

#### Mitigation Strategies

**Prevention:**

1. **Scalable Architecture**
   - Use serverless functions (Vercel, Railway - auto-scaling)
   - Database: PostgreSQL with read replicas
   - Caching: Redis for frequently accessed data
   - CDN: Cloudflare for static assets

2. **Efficient Database Design**
   - Proper indexing on frequently queried columns
   - Partition large tables by date (time-series data)
   - Archive old data (>2 years) to cold storage

3. **API Rate Limit Management**
   - Batch API requests where possible
   - Cache wearable data (refresh every 6-24 hours, not real-time)
   - Implement request queues (not all users need instant refresh)

4. **AI Cost Optimization**
   - Use GPT-4 for initial analysis (high quality)
   - Use GPT-3.5 for daily coaching (lower cost)
   - Cache common recommendations (don't regenerate identical advice)
   - Implement prompt compression techniques

**Detection:**

5. **Performance Monitoring**
   - Track response times (p50, p95, p99)
   - Alert if page load >3 seconds
   - Database query performance monitoring (slow query log)
   - API cost tracking (alert if >$0.50/user/month)

6. **Load Testing**
   - Quarterly load tests (simulate 3x current traffic)
   - Identify bottlenecks before they hit production
   - Test at 10x scale (know where system breaks)

**Response:**

7. **Scaling Playbook**
   - Document steps to scale each component
   - Database: Add read replicas, upgrade instance
   - APIs: Implement queuing, reduce refresh frequency
   - AI: Switch to cheaper models for non-critical features

8. **Performance Budget**
   - Set targets: Page load <2s, API response <500ms
   - Monitor against targets monthly
   - Prioritize performance improvements if degrading

**Success Metrics:**
- Page load time: <2 seconds (p95)
- API response time: <500ms (p95)
- Database query time: <100ms (p95)
- AI cost per user: <CHF 2/month
- Uptime: >99.9%

---

## Market Risks

### Risk 6: Limited Market Size (Switzerland)

**Description:**
Swiss biohacker market is small:
- Total addressable market: ~8,000-12,000 active biohackers
- Serviceable obtainable market: ~3,000-5,000 (Year 3 target)
- Revenue ceiling: CHF 4-6M/year at 50% penetration

Risks:
- Can't scale beyond Swiss market (growth plateau)
- Not attractive to investors (small TAM)
- Revenue too small to support large team

**Severity:** Medium (limits growth but not fatal)

**Probability:** High (80% - market size is real constraint)

**Impact:**
- Year 3 revenue cap at CHF 4-5M (vs CHF 10M+ if larger market)
- Difficult to raise funding (investors want CHF 100M+ markets)
- Team size limited to 5-10 people

---

#### Mitigation Strategies

**Prevention:**

1. **DACH Expansion (Year 2-3)**
   - Germany: 50M market (5-7x larger than Switzerland)
   - Austria: 5M market (similar culture)
   - Combined TAM: 100,000+ potential users (vs 8,000 in Switzerland)
   - Expand in Year 2 after Switzerland product-market fit

2. **Adjacent Market Expansion**
   - Lite tier: Casual health trackers (5x larger market)
   - Female-focused: Hormone optimization, menstrual tracking
   - B2B: Employers buy for employees (5-10x market size)

3. **Deep Market Penetration**
   - Focus on 50%+ penetration of Swiss biohacker market
   - Build defensible moat (brand, community, partnerships)
   - High LTV (CHF 3,000+) compensates for smaller volume

**Response:**

4. **Bootstrap & Profitability Focus**
   - Don't raise VC (avoid pressure for hypergrowth)
   - Target profitability by Month 8 (not dependent on next round)
   - Sustainable business at CHF 2-5M revenue (Year 2-3)

5. **Geographic Expansion Timeline**
   - Year 1: Switzerland only (validate model)
   - Year 2: Germany + Austria (3x market)
   - Year 3: Netherlands, UK (10x market)
   - Year 4+: US expansion (50x market)

6. **Adjacent Product Lines**
   - Year 2: CGM analysis add-on (CHF 29/month)
   - Year 3: Genetic data integration (CHF 99 one-time)
   - Year 3: B2B enterprise tier (volume sales)

**Success Metrics:**
- Switzerland market penetration: 30-50% by Year 3
- DACH expansion begins: Month 18-24
- Revenue growth: +150-300% YoY (Year 1-3)
- Profitability: Positive from Month 8

---

### Risk 7: Low Conversion Rate (Analysis → Subscription)

**Description:**
Business model depends on converting one-time analysis buyers to subscribers:
- Target: 60-70% convert within 90 days
- Reality: Could be 30-40% if value isn't clear

Impact:
- 50% lower subscription revenue (CHF 160K vs CHF 320K in Year 1)
- LTV drops from CHF 1,562 to CHF 900
- Profitability delayed or marginal

**Severity:** High (threatens business model)

**Probability:** Medium (30-40% - conversion is uncertain)

**Impact:**
- Year 1 revenue: CHF 155K instead of CHF 236K (-34%)
- Year 1 EBITDA: CHF 21K instead of CHF 102K (-79%)
- Break-even: Month 12 instead of Month 8

---

#### Mitigation Strategies

**Prevention:**

1. **Product Optimization for Conversion**
   - Analysis report includes: "See how these recommendations work in real-time with Daily Coach"
   - Show mock-up of daily morning brief (preview of subscription)
   - Include 7-day free trial of Daily Coach with analysis purchase

2. **Onboarding Nurture Sequence**
   - Day 0: Deliver analysis report
   - Day 2: Email "How to act on your analysis" + intro Daily Coach
   - Day 5: Email "Try Daily Coach free for 14 days"
   - Day 7: Email case study (user testimonial)
   - Day 14: Email "Your trial ends tomorrow" (urgency)

3. **Quick Wins in First Week**
   - Show wearable correlation immediately (wow moment)
   - Send first daily coaching recommendation (teaser)
   - Email: "Your HRV is 12% above baseline today - optimal for HIIT"

4. **Value Demonstration**
   - Compare: "You just spent CHF 149 on analysis... now use it daily for CHF 79/month"
   - Show ROI: "Track your protocol efficacy - see if supplements are working"
   - Social proof: "87% of users who upgrade say Daily Coach is essential"

**Detection:**

5. **Conversion Funnel Tracking**
   - Track conversion rate by cohort (weekly)
   - A/B test pricing, messaging, trial length
   - Identify drop-off points (email opens, trial starts, trial-to-paid)

6. **User Interviews**
   - Monthly interviews with non-converters
   - "Why didn't you upgrade to Daily Coach?"
   - Identify objections and improve product/messaging

**Response:**

7. **Pricing Adjustments**
   - If conversion <50% after 3 months:
     - Test lower price (CHF 59/month vs CHF 79)
     - Test longer trial (30 days vs 14 days)
     - Test discount ("First 3 months CHF 59, then CHF 79")

8. **Feature Prioritization**
   - If users say "Daily Coach isn't valuable enough":
     - Accelerate high-value features (nutrition, recovery, illness detection)
     - Improve daily brief quality (more personalized, actionable)

9. **Fallback: Analysis-Only Model**
   - If conversion <40%:
     - Pivot to higher analysis pricing (CHF 199 vs CHF 149)
     - Focus on repeat analysis purchases (4x/year)
     - Subscription becomes premium add-on (not core)

**Success Metrics:**
- Conversion rate: >60% within 90 days (target)
- Trial start rate: >80% of analysis buyers
- Trial-to-paid rate: >70%
- Time to first subscription: <14 days avg

---

### Risk 8: High Churn Rate

**Description:**
Subscription churn is critical to unit economics:
- Target: 4% monthly churn (60% annual retention)
- Reality: Could be 8-10% if product isn't sticky

Impact:
- Average subscription duration: 10 months instead of 18
- LTV drops from CHF 1,562 to CHF 900
- Need 2x more acquisition to hit revenue targets

**Severity:** High (threatens profitability)

**Probability:** Medium (30-40% - retention is hard)

**Impact:**
- Year 1 MRR: CHF 18K instead of CHF 32K (-43%)
- Year 1 revenue: CHF 170K instead of CHF 236K (-28%)
- LTV:CAC drops from 17.5:1 to 9:1 (still healthy but concerning)

---

#### Mitigation Strategies

**Prevention:**

1. **Habit Formation (Month 1-3)**
   - Daily engagement: Morning brief delivered consistently at 6-7am
   - Weekly check-ins: "How are you feeling this week?"
   - Tutorial content: "How to maximize Daily Coach value"
   - Quick wins: Show measurable improvements early

2. **Value Reinforcement**
   - Weekly summary: "Your HRV improved 8% this week"
   - Protocol tracking: "Day 30 of magnesium protocol - sleep +15%"
   - Progress visualization: Charts showing biomarker + wearable trends

3. **Retest Cycle Alignment**
   - Users most likely to churn: 90-120 days (between retests)
   - Solution: Promote quarterly Premium plan (includes retests)
   - Reminder: "Time to retest vitamin D - upgrade to Premium, retest included"

4. **Community Features (Year 2)**
   - User forum: Share protocols, ask questions
   - Social accountability: "5-day streak of following recommendations"
   - Peer comparison: "Your HRV is top 20% of Swiss biohackers"

5. **Annual Plans**
   - 10% discount for annual payment (CHF 849 vs CHF 948)
   - Locks in users for 12 months (reduces churn risk)
   - Target: 30-40% of subscribers on annual plans

**Detection:**

6. **Churn Risk Scoring**
   - Flag high-risk users:
     - No wearable connection after 7 days
     - Daily brief emails unopened for 7+ days
     - No protocol check-ins for 14 days
   - Automated intervention: "We noticed you haven't been using... need help?"

7. **Cohort Analysis**
   - Track retention by cohort (weekly)
   - Identify patterns (which acquisition channel has best retention?)
   - Survey canceling users: "Why are you leaving?"

**Response:**

8. **Win-Back Campaigns**
   - Users who cancel:
     - Email Day 7: "We miss you - here's 20% off to come back"
     - Email Day 30: "New features you might like..."
     - Email Day 90: "Time for your next retest - we can help"

9. **Personalized Interventions**
   - High-risk user flagged:
     - Personal email from founder (Year 1)
     - Offer 1-on-1 onboarding call (15 min)
     - Troubleshoot: "What's not working for you?"

10. **Retention Features**
    - If churn >6% monthly:
      - Accelerate sticky features (community, advanced visualizations)
      - Test lower pricing (CHF 69 vs CHF 79)
      - Add pause option ("Pause 3 months, don't cancel")

**Success Metrics:**
- Monthly churn: <4% (target), <6% (acceptable), >8% (red flag)
- Annual retention: >60% (target), >50% (acceptable)
- Churn by reason: Track and address top 3 reasons
- Win-back rate: >15% of canceled users return within 6 months

---

### Risk 9: Well-Funded Competitor Enters Market

**Description:**
Larger competitor with more resources could enter Swiss market:
- InsideTracker adds daily coaching + wearables (raise $50M)
- Oura acquires lab company and builds analysis features
- New startup raises CHF 5-10M seed for Swiss market

Risks:
- Outspend us on marketing (10x budget)
- Faster product development (larger team)
- Better partnerships (Oura exclusive, lab integrations)
- Price war (subsidize to gain market share)

**Severity:** Medium (threatens growth but not survival)

**Probability:** Medium (40-50% - attractive market)

**Impact:**
- Slower growth (users choose competitor)
- Lower CAC efficiency (higher ad costs due to competition)
- Margin compression (forced to lower prices)
- Acquisition by competitor (positive exit)

---

#### Mitigation Strategies

**Prevention:**

1. **First-Mover Advantage**
   - Launch fast (6-12 month head start matters)
   - Lock in early adopters (switching costs after 6 months of data)
   - Build brand in Swiss community (reddit, FB groups, events)

2. **Moat Building**
   - Proprietary frameworks (17 frameworks = 2+ years to replicate)
   - Swiss market knowledge (language, labs, culture)
   - Partnerships (Oura, Biostarks) - lock in with contracts
   - Data moat (more users = better recommendations)

3. **Capital Efficiency**
   - Bootstrap to profitability (Month 8)
   - Don't need to raise → can't be outspent easily
   - Lower CAC (content + community vs paid ads)

4. **Focus on Swiss Niche**
   - Competitors target global market (diluted focus)
   - We own Swiss market (deep relationships, brand)
   - Hard for international player to displace local champion

**Response:**

5. **If InsideTracker Adds Daily Coaching:**
   - Emphasize Swiss focus (local partnerships, language, culture)
   - Price competitively (CHF 79 vs their likely $99-149)
   - Partner with Oura (exclusive Swiss discount)

6. **If Oura Builds Lab Integration:**
   - Pivot to partnership (become their Swiss analysis partner)
   - Offer to white-label our analysis for them
   - Focus on differentiators (17 frameworks, daily adaptation)

7. **If New Startup Raises Large Round:**
   - Double down on community (can't be outspent here)
   - Focus on quality over growth (better retention)
   - Consider acquisition offer (positive exit)

8. **Price War Defense:**
   - Don't engage in race to bottom
   - Maintain premium positioning (quality over price)
   - Focus on LTV (sticky users, not cheap acquisition)

**Success Metrics:**
- Brand awareness in Swiss market: >60% by Year 2
- Net Promoter Score: >50 (defensibility through loyalty)
- Customer lifetime: >18 months (high switching costs)
- Partnerships locked: 2-3 year contracts (by Year 2)

---

## Regulatory Risks

### Risk 10: Medical Device Classification

**Description:**
Platform could be classified as medical device by Swissmedic:
- Medical device: Requires certification (CHF 50-100K, 12-18 months)
- Diagnosis/treatment tool: Can't market as "medical advice"
- Regulatory enforcement: Platform shut down until certified

**Severity:** Critical (could shut down business)

**Probability:** Low (10-15% - if positioned correctly)

**Impact:**
- Business shutdown for 12-18 months (certification process)
- CHF 50-100K certification costs
- Ongoing compliance costs (CHF 20-30K/year)
- Restrictions on marketing claims

---

#### Mitigation Strategies

**Prevention:**

1. **Wellness Positioning (Not Medical)**
   - Market as: "Health optimization platform" (wellness)
   - NOT: "Diagnose diseases" or "treat conditions" (medical)
   - Emphasize: "Informational and educational purposes only"

2. **Clear Disclaimers**
   - Every report: "This is not medical advice. Always consult your doctor."
   - Terms of Service: Platform is wellness guidance, not diagnosis
   - No claims about diagnosing, treating, or curing diseases

3. **No Diagnosis Features**
   - Don't say: "You have diabetes" or "You have thyroid disease"
   - Do say: "Your glucose is elevated - discuss with your doctor"
   - Focus on optimization (improve what's already functional)

4. **Doctor Collaboration Model**
   - Position as tool to augment doctor visits (not replace)
   - Doctor-shareable reports (formatted for medical review)
   - "Bring this report to your next doctor appointment"

5. **Legal Review**
   - Hire Swiss health tech lawyer (Year 1, Month 1)
   - Review marketing copy, disclaimers, ToS
   - Ensure compliance with Swissmedic regulations

**Detection:**

6. **Monitor Regulatory Changes**
   - Subscribe to Swissmedic updates (quarterly review)
   - Watch EU MDR changes (often influence Swiss rules)
   - Consult lawyer annually on compliance

**Response:**

7. **If Contacted by Swissmedic:**
   - Respond immediately (within 48 hours)
   - Provide documentation (marketing, disclaimers, ToS)
   - Emphasize wellness positioning
   - Hire lawyer to represent us

8. **Pivot Strategy (If Required to Certify):**
   - Pause new customer acquisition
   - Maintain existing users (don't shut down)
   - Begin certification process (12-18 months)
   - Raise funding to cover certification costs

**Success Metrics:**
- Regulatory inquiries: 0
- Legal review: Annual sign-off on compliance
- Disclaimer visibility: 100% of users see disclaimers
- Medical claims: 0 (automated scanning of marketing copy)

---

### Risk 11: Data Privacy Violations (GDPR, Swiss DPA)

**Description:**
Platform handles sensitive health data subject to GDPR + Swiss DPA:
- Improper consent → CHF 20M or 4% revenue fine
- Data breach → Must notify within 72 hours
- User rights violations (access, deletion) → Fines
- Cross-border data transfer → Special requirements

**Severity:** High (large fines + reputational damage)

**Probability:** Low (10% - if proper compliance measures)

**Impact:**
- Fines: CHF 1,000-20M per violation
- Regulatory investigation (Swiss FDPIC)
- Business shutdown (if serious violations)
- Loss of user trust → 100% churn

---

#### Mitigation Strategies

**Prevention:**

1. **GDPR Compliance by Design**
   - Privacy policy: Clear, simple language (not legalese)
   - Consent: Explicit opt-in for data processing
   - User rights: Easy access, export, deletion
   - Data minimization: Only collect necessary data

2. **Swiss Data Hosting**
   - Host in Switzerland or EU (not US)
   - Use Swiss/EU cloud providers (Infomaniak, Hetzner)
   - No data transfer to US (avoid CLOUD Act issues)

3. **Data Processing Agreement (DPA)**
   - Sign DPAs with all vendors (Oura, Stripe, email providers)
   - Ensure vendors are GDPR compliant
   - Audit vendor compliance annually

4. **User Rights Implementation**
   - Data export: One-click download of all user data (JSON/PDF)
   - Data deletion: Account deletion removes all data within 30 days
   - Data access: User can view all data we store
   - Consent management: User can revoke consent anytime

5. **Privacy by Design**
   - Pseudonymization: Separate PII from health data (different databases)
   - Encryption: All sensitive data encrypted at rest + in transit
   - Access controls: Role-based access (employees see minimum necessary)

**Detection:**

6. **Compliance Monitoring**
   - Annual GDPR audit (internal or third-party)
   - Track user rights requests (respond within 30 days)
   - Monitor data processing activities (log all access)

**Response:**

7. **Data Breach Response Plan**
   - Detect breach within 24 hours (monitoring alerts)
   - Notify Swiss FDPIC within 72 hours (legal requirement)
   - Notify affected users within 72 hours
   - Document breach (what, when, how many users, mitigation)

8. **User Rights Request Process**
   - User submits request (data access, export, deletion)
   - Verify identity (prevent unauthorized access)
   - Respond within 30 days (legal requirement)
   - Log all requests (for audit trail)

**Success Metrics:**
- GDPR compliance audit: Pass with no major findings
- User rights requests: 100% fulfilled within 30 days
- Data breaches: 0
- Swiss FDPIC inquiries: 0

---

### Risk 12: Medical Advice Liability

**Description:**
User follows platform recommendations and experiences harm:
- Supplement overdose (e.g., vitamin D toxicity)
- Adverse reaction to supplement (e.g., allergy)
- Delayed medical treatment (user ignores serious symptoms)
- Interaction with medications (e.g., St. John's Wort + antidepressants)

Legal risks:
- Lawsuit for negligence or malpractice
- CHF 100K-1M damages per incident
- Regulatory investigation (Swissmedic, cantonal health authorities)

**Severity:** High (financial + legal + reputational)

**Probability:** Medium (20-30% - supplements have risks)

**Impact:**
- Legal costs: CHF 50-100K per lawsuit
- Damages: CHF 100K-1M if lose case
- Insurance premium increase
- Negative press (reputation damage)

---

#### Mitigation Strategies

**Prevention:**

1. **Strong Disclaimers**
   - Every report: "This is not medical advice. Consult your doctor before starting supplements."
   - Supplement protocols: "Do not exceed recommended doses without medical supervision"
   - High-risk biomarkers: "This may indicate a serious condition - see your doctor immediately"

2. **Conservative Recommendations**
   - Doses: Stay at lower end of therapeutic range
   - Known risks: Flag interactions (e.g., blood thinners + omega-3)
   - Contraindications: "Do not take X if you have Y condition"
   - Medical urgency: "This requires immediate medical attention - do not delay"

3. **Terms of Service Protection**
   - User acknowledges: Platform is informational, not medical advice
   - User agrees: Consult doctor before making health changes
   - Limitation of liability: Capped at amount paid (CHF 149-1,548)
   - Arbitration clause: Avoid expensive lawsuits

4. **Medical Advisor Review**
   - Hire functional medicine doctor (advisor, Year 1 Month 6)
   - Review sample of analyses quarterly (10% random sample)
   - Update protocols based on advisor feedback

5. **AI Safety Guardrails**
   - Validation layer: Reject recommendations outside safe ranges
   - Interaction checking: Flag known dangerous combinations
   - Medical urgency detection: Escalate serious biomarkers

**Detection:**

6. **User Harm Reporting**
   - "Report an issue" button on every report
   - Customer support trained to escalate health concerns
   - Track adverse events (even if not our fault)

7. **Medical Advisor Oversight**
   - Review 10% of analyses quarterly
   - Identify systematic issues
   - Update protocols to prevent recurrence

**Response:**

8. **Incident Response**
   - User reports harm:
     - Respond within 24 hours
     - Offer to connect with human health advisor (free)
     - Document incident (what, when, how severe)
     - Report to insurance carrier
     - Update protocols to prevent recurrence

9. **Legal Defense**
   - Liability insurance: CHF 1M coverage (Year 1), CHF 5M (Year 2+)
   - Hire lawyer immediately if lawsuit filed
   - Document: Disclaimer was shown, user acknowledged ToS
   - Defense: Platform is informational, user chose to follow advice

**Success Metrics:**
- User-reported harm: 0 (zero tolerance)
- Insurance claims: 0
- Lawsuits: 0
- Advisor approval rate: >98% on sample reviews

---

## Business Risks

### Risk 13: Founder Burnout

**Description:**
Founder is single point of failure (technical, product, marketing, operations):
- Working 60-80 hours/week (not sustainable)
- No backup if founder becomes ill or unavailable
- Quality degrades as founder stretched thin
- Motivation drops → business suffers

**Severity:** High (business fails if founder quits)

**Probability:** Medium (30-40% - startups are hard)

**Impact:**
- Business shutdown (no one to run it)
- Quality decline → user churn
- Missed opportunities (can't execute fast enough)

---

#### Mitigation Strategies

**Prevention:**

1. **Sustainable Pace**
   - Work 50-60 hours/week max (not 80)
   - Take 1 day off per week (Saturday or Sunday)
   - 2-week vacation annually (Year 1+)
   - Morning routine (exercise, meditation)

2. **Hire Help Early**
   - Month 3: Part-time VA for customer support (10 hours/week)
   - Month 6: Contract developer for feature work (20 hours/week)
   - Month 9: Part-time content writer (10 hours/week)

3. **Automation & Leverage**
   - Automate: Email sequences, payment processing, data syncing
   - Delegate: Customer support (VA), development (contractor), content (writer)
   - Focus founder time: Product decisions, key partnerships, fundraising (if needed)

4. **Support System**
   - Join founder community (Swiss startup scene, online forums)
   - Monthly mastermind calls (other founders)
   - Advisor or mentor (check-ins every 6 weeks)

**Detection:**

5. **Burnout Warning Signs**
   - Working >70 hours/week for 2+ weeks
   - Dreading work (Sunday night dread)
   - Quality slipping (bugs, missed deadlines)
   - Health issues (sleep problems, weight gain/loss)

**Response:**

6. **If Burnout Occurs:**
   - Take 1-2 weeks off (force reset)
   - Hire help immediately (even if expensive)
   - Cut scope (pause new features, focus on retention)
   - Consider co-founder or key hire

7. **Exit Strategy**
   - If unsustainable:
     - Sell business (to competitor or operator)
     - Shut down gracefully (refund annual users)
     - Hire CEO (founder becomes advisor)

**Success Metrics:**
- Founder work hours: <60 hours/week average
- Vacation days: 10+ per year
- Net Promoter Score (motivation proxy): >50
- Team size: 1 → 2-3 (Year 1), 5-8 (Year 2)

---

### Risk 14: Cash Flow Issues

**Description:**
Even if business is profitable, cash flow can be tight:
- Customers pay monthly but costs are upfront (development, marketing)
- Refunds for unhappy customers
- Unexpected expenses (legal issue, security incident)
- Seasonal slowdowns (summer vacation → lower signups)

**Severity:** Medium (can be managed but painful)

**Probability:** Low (15-20% - if properly capitalized)

**Impact:**
- Can't pay vendors (infrastructure shut down)
- Can't pay contractors (development halts)
- Personal financial stress for founder
- Forced to raise emergency funding (bad terms)

---

#### Mitigation Strategies

**Prevention:**

1. **Initial Capital Buffer**
   - Start with CHF 25-40K runway (6 months expenses)
   - Source: Founder savings, pre-sales, small business loan

2. **Conservative Burn Rate**
   - Fixed costs: Keep <CHF 5K/month (Year 1)
   - Avoid large upfront commitments (annual contracts)
   - Hire contractors (flexible) vs employees (fixed cost)

3. **Annual Plans**
   - Push annual subscriptions (10% discount)
   - Upfront cash: CHF 849-1,399 vs CHF 79-129/month
   - Target: 30-40% of subscribers on annual plans

4. **Pre-Sales & Beta Pricing**
   - Months 1-3: Offer 20% discount for upfront payment
   - 20 early adopters × CHF 119 = CHF 2,380 upfront cash

**Detection:**

5. **Cash Flow Monitoring**
   - Track runway weekly (months of cash remaining)
   - Alert if runway <3 months (need to raise or cut costs)
   - Forecast: Project cash flow 6 months ahead

**Response:**

6. **If Cash Runs Low:**
   - Cut non-essential costs (pause marketing, reduce contractor hours)
   - Focus on revenue (push annual upgrades, win-back campaigns)
   - Delay personal salary (if founder can afford)
   - Small business loan (CHF 20-50K, quick approval)
   - Emergency fundraise (angel investors, friends & family)

7. **Payment Flexibility**
   - Negotiate: Pay vendors Net 30 or Net 60 (not upfront)
   - Credit card: Use for 30-day float (pay before interest)

**Success Metrics:**
- Runway: >6 months cash at all times
- Monthly burn: <CHF 8K (Year 1)
- Cash flow positive: Month 8 onwards
- Emergency fund: CHF 10-20K buffer by Month 12

---

### Risk 15: Key Person Dependency

**Description:**
Founder has all knowledge and access:
- Technical: Only person who knows codebase
- Product: All product decisions
- Business: Only person with partner relationships
- Operations: Only person with vendor logins

Risks:
- Founder unavailable (illness, accident) → business halts
- Founder quits → business shuts down
- Quality bottleneck → slow feature development

**Severity:** High (single point of failure)

**Probability:** High (90% - inherent in solo founder)

**Impact:**
- Business shutdown if founder unavailable
- Slow execution (founder is bottleneck)
- No succession plan (can't sell or exit)

---

#### Mitigation Strategies

**Prevention:**

1. **Documentation**
   - Technical: Code comments, architecture docs, deployment guide
   - Product: Roadmap, user research, design decisions
   - Operations: Vendor list with logins (password manager)
   - Business: Partner contacts, legal documents, financials

2. **Knowledge Transfer**
   - Hire contract developer (Month 6):
     - Train on codebase
     - Pair programming sessions
     - Can maintain system if founder unavailable
   - Hire VA for operations (Month 3):
     - Access to support email
     - Can handle basic customer issues

3. **Bus Factor Mitigation**
   - Password manager (1Password, Bitwarden) with emergency access
   - Give trusted person (co-founder, advisor) emergency access
   - Document: "If I'm unavailable for >7 days, here's what to do"

4. **Hire Key Roles**
   - Year 1: Contract developer (technical backup)
   - Year 2: Full-time developer (can own product)
   - Year 2: Operations manager (customer support, vendors)

**Detection:**

5. **Bottleneck Monitoring**
   - Track: How many decisions/tasks depend on founder?
   - Goal: Founder makes <70% of decisions by Month 12
   - Red flag: Founder working >70 hours/week (sign of bottleneck)

**Response:**

6. **If Founder Unavailable:**
   - Emergency contact (advisor, friend) has access to:
     - Password manager (all vendor logins)
     - Bank account (can pay critical bills)
     - Customer list (can notify users)
   - Plan: Keep business running for 30-60 days, then decide (sell, shut down, hire)

7. **Succession Planning (Year 2+)**
   - Identify potential CEO hire (if founder wants to exit)
   - Document: Everything needed to run business
   - Train: Key hire can operate independently by Month 18

**Success Metrics:**
- Documentation coverage: 80% of systems documented
- Bus factor: >2 (at least 2 people can handle critical tasks)
- Founder decision dependency: <70% by Month 12
- Succession plan: Documented by Year 2

---

### Risk 16: Partnership Failures

**Description:**
Business relies on partnerships for growth:
- Oura Ring: Referral partnership, data integration
- Biostarks: Lab data import, cross-promotion
- Supplement brands: Affiliate revenue

Risks:
- Partnership doesn't materialize (negotiations fail)
- Partner changes terms (higher fees, less promotion)
- Partner terminates relationship
- Partner acquired (new owner terminates deal)

**Severity:** Medium (hurts growth but not fatal)

**Probability:** Medium (40-50% - partnerships are hard)

**Impact:**
- Lower growth (lose acquisition channel)
- Lost revenue (10-20% from affiliates)
- Feature limitations (no automated data import)

---

#### Mitigation Strategies

**Prevention:**

1. **Diversify Partnerships**
   - Wearables: Integrate 4+ (Oura, Whoop, Apple, Garmin)
   - Labs: Partner with 2-3 Swiss labs (not just Biostarks)
   - Affiliates: 5-10 supplement brands (not dependent on one)

2. **Formal Contracts**
   - Written agreement (not handshake deal)
   - Terms: 1-2 year minimum, clear termination clause
   - Exclusivity: Avoid if possible (don't lock us in)

3. **Build Without Dependency**
   - Don't rely on partnerships for core features
   - Partnerships = growth accelerators (not requirements)
   - Core product works without partnerships

**Detection:**

4. **Partnership Health Monitoring**
   - Quarterly check-ins with key partners
   - Track: Referral volume, API uptime, communication frequency
   - Red flags: Delayed responses, declining referrals, API issues

**Response:**

5. **If Partnership Fails:**
   - Oura terminates: Use Apple Health as alternative data source
   - Biostarks terminates: Focus on other Swiss labs (Hirslanden, Medisupport)
   - Supplement affiliate ends: Find replacement partner (Thorne, Pure Encapsulations)

6. **Backup Plans**
   - Always have 2+ options for critical partnerships
   - Don't announce partnership until contract signed
   - Be prepared to walk away (don't accept bad terms)

**Success Metrics:**
- Active partnerships: 3-5 by Year 1
- Partnership revenue: <20% of total (not dependent)
- Contract terms: 1-2 year minimum (stability)
- Partnership NPS: >70 (both sides happy)

---

## Strategic Risks

### Risk 17: Wrong Product-Market Fit

**Description:**
Hypothesis: Swiss biohackers want lab + wearable analysis + daily coaching
Reality: They only want lab analysis (no need for daily coaching)

Or: They want different features than we built

**Severity:** High (business fails if no PMF)

**Probability:** Low (15-20% - strong demand signals)

**Impact:**
- Low conversion (analysis → subscription)
- High churn (users don't find value)
- Business fails to reach profitability

---

#### Mitigation Strategies

**Prevention:**

1. **Customer Discovery (Pre-Launch)**
   - Interview 20-30 target users before building
   - Validate: Will you pay CHF 149 for this? CHF 79/month?
   - Show mockups, get feedback on features

2. **MVP Testing**
   - Launch with 20-30 beta users (Months 1-3)
   - Test: Do they convert to subscription? Do they find value?
   - Iterate based on feedback before scaling marketing

3. **Pre-Sales Validation**
   - Sell before building (take pre-orders)
   - Goal: 20 pre-orders at CHF 119 (discounted)
   - If can't sell, don't build (pivot or kill idea)

**Detection:**

4. **PMF Metrics**
   - Survey: "How would you feel if you could no longer use this product?"
     - >40% say "Very disappointed" = strong PMF
   - NPS: >50 = strong PMF
   - Organic growth: >10% users from referrals = PMF
   - Retention: >60% annual = PMF

5. **User Feedback**
   - Monthly user interviews (5-10 users)
   - "What would make this product indispensable for you?"
   - Identify gaps between expectations and reality

**Response:**

6. **If Weak PMF:**
   - Pivot: Change features (e.g., remove daily coach, focus on deep analysis)
   - Pivot: Change market (e.g., focus on athletes vs biohackers)
   - Pivot: Change price (e.g., CHF 49/month vs CHF 79)
   - Kill: Refund users, shut down (if no path to PMF)

7. **Feature Iteration**
   - If users say "I'd pay if you added X":
     - Build X in next sprint
     - Retest with users
     - Repeat until PMF achieved

**Success Metrics:**
- "Very disappointed" metric: >40% by Month 6
- NPS: >50 by Month 6
- Conversion rate: >60% by Month 6
- Annual retention: >60% by Month 12

---

### Risk 18: Timing (Too Early or Too Late)

**Description:**
Market timing is critical:
- Too early: Users don't understand value, not ready to pay
- Too late: Market saturated, competitors entrenched

**Severity:** Medium (can adjust but limits upside)

**Probability:** Low (10-15% - timing looks good)

**Impact:**
- Too early: Slow adoption, high customer education cost
- Too late: Expensive CAC (compete with entrenched players)

---

#### Mitigation Strategies

**Detection:**

1. **Market Readiness Signals**
   - Wearable adoption: 70%+ of Swiss biohackers own Oura/Whoop (✅)
   - Lab testing frequency: Quarterly or bi-annual (✅)
   - Competitor landscape: No one offers lab + wearable + daily coaching (✅)
   - Willingness to pay: Users spend CHF 5K-10K/year on health (✅)

2. **Early Adopter Engagement**
   - Beta users (Months 1-3): Do they "get it" immediately?
   - If yes: Good timing (early adopters eager)
   - If no: Might be too early (need more education)

**Response:**

3. **If Too Early:**
   - Focus on education (content marketing, webinars)
   - Target super early adopters (Bryan Johnson followers)
   - Be patient (market will mature in 12-24 months)

4. **If Too Late:**
   - Focus on differentiation (Swiss market, proprietary frameworks)
   - Partner with incumbents (become Oura's Swiss partner)
   - Consider acquisition by competitor (exit)

**Success Metrics:**
- Time to explain value: <2 minutes (users "get it" quickly)
- Beta user excitement: High (NPS >60)
- Organic interest: Inbound requests before launch

---

### Risk 19: Pricing Strategy Failure

**Description:**
Pricing is wrong for market:
- Too high: Users won't pay (low conversion)
- Too low: Users perceive as low quality, or not enough margin
- Wrong model: Should be one-time only, or subscription only

**Severity:** Medium (can adjust but affects growth)

**Probability:** Medium (30-40% - pricing is hard)

**Impact:**
- Too high: 50% lower conversion → 50% lower revenue
- Too low: 30% lower margins → profitability at risk

---

#### Mitigation Strategies

**Prevention:**

1. **Willingness to Pay Research**
   - Interview target users: "What would you pay for this?"
   - Van Westendorp Price Sensitivity: Find optimal price range
   - Compare to alternatives: InsideTracker ($129-589), Functional medicine (CHF 300-500)

2. **Test Multiple Price Points**
   - Beta launch: Test CHF 119, CHF 149, CHF 179 (A/B test)
   - Subscription: Test CHF 69, CHF 79, CHF 99 (A/B test)
   - Measure: Conversion rate × LTV (not just conversion rate)

3. **Hybrid Model**
   - Offer both one-time and subscription (flexibility)
   - Users choose what fits their needs
   - Reduces risk of "wrong model"

**Detection:**

4. **Pricing Metrics**
   - Conversion rate: Low (<40%) = price too high or value unclear
   - Churn rate: High (>8%) = price not worth value
   - Price complaints: Track in customer feedback

**Response:**

5. **Price Adjustments**
   - If conversion <50%:
     - Test lower price (CHF 59 vs CHF 79)
     - Add 14-day trial (reduce perceived risk)
     - Bundle discount (CHF 129 analysis + 3 months subscription)

6. **Value Addition (Not Price Cuts)**
   - If price seems high:
     - Add features (make it worth more)
     - Better marketing (communicate value)
     - Social proof (testimonials, case studies)

**Success Metrics:**
- Conversion rate: >60% (target)
- Price complaints: <10% of feedback
- Upgrade rate (Daily Coach → Premium): >25%
- Annual plan adoption: >30% of subscribers

---

## Risk Mitigation Summary

### Critical Priorities (Address Immediately)

1. **AI Safety Guardrails** - Prevent bad medical advice (Risk 3)
2. **Data Security** - Encrypt data, GDPR compliance (Risk 4)
3. **Medical Device Positioning** - Wellness not medical (Risk 10)
4. **Legal Disclaimers** - Liability protection (Risk 12)

### High Priorities (Address in First 6 Months)

5. **OCR Accuracy** - Multi-stage pipeline, user verification (Risk 1)
6. **Conversion Optimization** - Analysis → subscription funnel (Risk 7)
7. **Retention Features** - Daily engagement, value reinforcement (Risk 8)
8. **Founder Support** - Hire help, sustainable pace (Risk 13)

### Medium Priorities (Monitor & Adjust)

9. **API Resilience** - Multi-wearable strategy, caching (Risk 2)
10. **Market Size** - Plan DACH expansion (Risk 6)
11. **Competitive Moats** - Partnerships, proprietary frameworks (Risk 9)
12. **Cash Flow Management** - Annual plans, conservative burn (Risk 14)

### Ongoing Monitoring

13. **Product-Market Fit** - Monthly NPS, user interviews (Risk 17)
14. **Pricing Strategy** - A/B testing, willingness to pay (Risk 19)
15. **Partnership Health** - Quarterly check-ins (Risk 16)

---

## Risk Dashboard (Quarterly Review)

| Quarter | Key Risks to Monitor | Success Metrics |
|---------|---------------------|-----------------|
| **Q1** | AI safety, data security, OCR accuracy | 0 safety incidents, 0 breaches, >90% OCR accuracy |
| **Q2** | Conversion rate, retention, PMF signals | >60% conversion, <5% churn, >40% "very disappointed" |
| **Q3** | Competitor moves, CAC efficiency, cash flow | No major competitors, CAC <CHF 100, >3 months runway |
| **Q4** | Annual retention, pricing, profitability | >60% annual retention, NPS >50, profitable month |

---

## Conclusion

**Overall Risk Profile:** Moderate

**Key Strengths:**
- Technical risks manageable (proven tech stack)
- Strong unit economics (17.5:1 LTV:CAC)
- Capital efficient (profitable Month 8)
- Clear differentiation (no direct competitor)

**Key Risks:**
- Market size limited (8K-12K Swiss biohackers)
- Conversion uncertainty (60-70% target)
- Regulatory complexity (medical advice gray area)
- Founder dependency (solo founder)

**Mitigation Strategy:**
- Build defensible moats (proprietary frameworks, Swiss focus)
- Move fast (6-12 month head start matters)
- Bootstrap to profitability (reduce external dependencies)
- Plan DACH expansion (grow market 10x by Year 3)

**Bottom Line:** Risks are manageable with proactive mitigation. Key is to execute fast, achieve PMF in Switzerland (Months 1-6), then expand to DACH region (Year 2-3). Strong unit economics provide margin of safety even if growth is slower than projected.
